<ѻýҕl>TXA Holds Its Own for Heavy Menstrual Bleeding in von Willebrand Diseaseѻýҕl> In phase III study, recombinant VWF not superior to cheaper alternative for type 1 and 2 cases Jun 29, 2023
<ѻýҕl>Continuing Trastuzumab After Progression Shows Promise in HER2+ Gastric/GEJ Cancerѻýҕl> Adding anti-HER2 agent to ramucirumab, paclitaxel exceeds historical PFS with doublet Jun 28, 2023
<ѻýҕl>Agent Orange Exposure Tied to Bladder Cancer Risk in Veteransѻýҕl> Increased risk described as "modest," and no association seen with aggressiveness of cancer Jun 27, 2023
<ѻýҕl>Can AI Help Determine If Liver Cancer Will Respond to Standard Treatment?ѻýҕl> Early model suggests a way to predict progression-free survival Jun 26, 2023
<ѻýҕl>Rates of Consent Withdrawal in Cancer Trials Low but Not 'Trivial'ѻýҕl> Factors associated with greater likelihood of withdrawal included Hispanic ethnicity, older age Jun 22, 2023
<ѻýҕl>Earlier Detection of Cardiac Dysfunction Possible for Young Adult Cancer Survivorsѻýҕl> A case for monitoring global longitudinal strain despite normal LVEF Jun 20, 2023
<ѻýҕl>Cystic Renal Masses Often Harbor High-Grade Diseaseѻýҕl> No link between grade and cancer-specific survival, active surveillance still an option for many Jun 16, 2023
<ѻýҕl>Pushback on Price Negotiation; Genetic Testing Lags; More Foreign Help for Shortagesѻýҕl> News, features, and commentary about cancer-related issues Jun 15, 2023
<ѻýҕl>CRISPR Therapy Exceeds Targets in Thalassemia, Sickle Cell Diseaseѻýҕl> Results "indicate that exa-cel can provide a one-time functional cure," says researcher Jun 13, 2023
<ѻýҕl>FGFR Inhibitor Stakes Claim to Post-Anti-PD-1 Role in Advanced Bladder Cancerѻýҕl> Survival benefit supports FGFR testing for all patients with metastatic disease, researcher says Jun 07, 2023
<ѻýҕl>No Survival Benefit With Immune Checkpoint Inhibitor Rechallenge in Metastatic RCCѻýҕl> The strategy also led to increased toxicity Jun 06, 2023
<ѻýҕl>Neoadjuvant Chemo Flops Versus Upfront Surgery for Resectable Pancreatic Cancerѻýҕl> Survival 13 months better with surgery, but "curiosities" in neoadjuvant arm muddy the results Jun 04, 2023
<ѻýҕl>Novel Anti-HER2 Drugs 'Impressive' in Advanced Biliary Cancerѻýҕl> Response rates reached 41-47% with different approaches in rare disease Jun 03, 2023
<ѻýҕl>Adaptive RT Fails to Relieve Dry Mouth in Head and Neck Cancerѻýҕl> "Expensive and intensive" process does not translate into clinical benefit, researchers conclude Jun 01, 2023
<ѻýҕl>No Access to Routine Healthcare Biggest Barrier to HPV Vaccinationѻýҕl> Retrospective analysis shows vaccination rates haven't much improved for women since 2015 May 25, 2023
<ѻýҕl>Medicaid Expansion Tied to Better Outcomes in Black Patients With GI Cancersѻýҕl> Two-year mortality decreased for three types of GI cancer in expansion vs non-expansion states May 25, 2023
<ѻýҕl>Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effectiveѻýҕl> Radical resection rate noninferior to open surgery in early-stage disease, with similar survival May 25, 2023
<ѻýҕl>Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancerѻýҕl> News, features, and commentary about cancer-related issues May 12, 2023
<ѻýҕl>Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Timeѻýҕl> Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
<ѻýҕl>Even at Stage IV, Immunotherapy Helps in Pancreatic Cancerѻýҕl> Small but clear boost to overall survival May 07, 2023
<ѻýҕl>Food 'Swamps' Tied to Elevated Mortality From Obesity-Related Cancersѻýҕl> Study suggests diet is not necessarily a modifiable risk factor for all, editorialists say May 05, 2023
<ѻýҕl>Novel Chemo Delivery System Achieves High Response Rate in Bladder Cancerѻýҕl> Complete responses in 73% of patients with BCG-unresponsive non-muscle-invasive disease May 02, 2023
<ѻýҕl>Thriving After Cancerѻýҕl> Tara Sanft, MD, on how clinicians can support patients through difficult times May 02, 2023 podcast
<ѻýҕl>'Fantastic,' 'Terrific' Results With Oncolytic Virus Combo for Bladder Cancerѻýҕl> Complete response rate of 85% in BCG-unresponsive non-muscle-invasive disease May 01, 2023
<ѻýҕl>Sperm Donor Banned Over Incest Fears; COVID Hampered Teen Sex; Jerry Springer Diesѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Apr 28, 2023
<ѻýҕl>Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Diveѻýҕl> News, features, and commentary about cancer-related issues Apr 21, 2023
<ѻýҕl>Awareness of HPV's Link to Cancer Lags as Cases Continue to Increaseѻýҕl> Clear decline for cervical cancer, awareness of other cancers remains stagnant Apr 21, 2023
<ѻýҕl>Novel Bispecific Antibody Active in Recurrent/Metastatic Head and Neck Cancerѻýҕl> Responses in 37% of patients previously treated with anti-PD-1/L1 agents, platinum chemotherapy Apr 18, 2023
<ѻýҕl>Including Anti-PD-1 in First-Line Ups Survival in Biliary Tract Cancerѻýҕl> Another option for difficult-to-treat disease Apr 17, 2023
<ѻýҕl>Adjuvant Combo May Change Practice in High-Risk Liver Cancerѻýҕl> Atezolizumab-bevacizumab reduced the risk of recurrence by about 30% Apr 17, 2023
<ѻýҕl>Blood Donor's Sex Makes No Difference for Survivalѻýҕl> Only difference seen was higher incidence of MRSA infection in recipients of female donor blood Apr 12, 2023
<ѻýҕl>Leading Causes of Death Hit Childhood Cancer Survivors Earlierѻýҕl> But excess risk lowest in survivors with a healthy lifestyle Apr 06, 2023
<ѻýҕl>CAR T-Cell Therapy Feasible, Safe in Advanced Neuroblastomaѻýҕl> ORR of 63% with GD2-targeting product in kids with relapsed, refractory high-risk disease Apr 06, 2023
<ѻýҕl>Major Survival Gain With Immunotherapy in Lymphomatoid Granulomatosisѻýҕl> Median overall survival reached 20 years with interferon alfa-2b in low-grade disease Apr 05, 2023
<ѻýҕl>FDA Greenlights New First-Line Regimen in Bladder Cancerѻýҕl> Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
<ѻýҕl>Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groupsѻýҕl> Overall risk and risk of endometrioid subtype 20- to 30-fold greater in women younger than 35 Mar 30, 2023
<ѻýҕl>A 'Double Whammy' for Gastric Cancer Riskѻýҕl> H. pylori infection and certain pathogenic variants linked with large excess risk Mar 29, 2023
<ѻýҕl>Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancerѻýҕl> Adding immunotherapy will change frontline treatment, experts say Mar 28, 2023
<ѻýҕl>No Survival Benefit With CRT Versus Chemo for Locally Advanced Endometrial Cancerѻýҕl> Long-running clinical trial failed to identify any subgroup that fared better with CRT Mar 27, 2023
<ѻýҕl>CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancerѻýҕl> Pathologic response rises to 73% versus 50% in historical control group Mar 27, 2023